KALA BIO, Inc. (KALA)
NASDAQ: KALA · Real-Time Price · USD
6.20
+0.02 (0.32%)
Nov 21, 2024, 10:07 AM EST - Market open

KALA BIO Statistics

Total Valuation

KALA BIO has a market cap or net worth of $28.57 million. The enterprise value is $12.23 million.

Market Cap 28.57M
Enterprise Value 12.23M

Important Dates

The last earnings date was Tuesday, November 12, 2024, before market open.

Earnings Date Nov 12, 2024
Ex-Dividend Date n/a

Share Statistics

KALA BIO has 4.61 million shares outstanding. The number of shares has increased by 53.04% in one year.

Current Share Class 4.61M
Shares Outstanding 4.61M
Shares Change (YoY) +53.04%
Shares Change (QoQ) +52.71%
Owned by Insiders (%) 3.91%
Owned by Institutions (%) 17.03%
Float 2.79M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio n/a
Forward PS n/a
PB Ratio 2.16
P/TBV Ratio 2.16
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

Current Ratio n/a
Quick Ratio n/a
Debt / Equity 2.68
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage -6.88

Financial Efficiency

Return on Equity (ROE) n/a
Return on Assets (ROA) n/a
Return on Capital (ROIC) -51.52%
Revenue Per Employee n/a
Profits Per Employee -$906,116
Employee Count 43
Asset Turnover n/a
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has increased by +3.94% in the last 52 weeks. The beta is -2.14, so KALA BIO's price volatility has been lower than the market average.

Beta (5Y) -2.14
52-Week Price Change +3.94%
50-Day Moving Average 6.06
200-Day Moving Average 6.58
Relative Strength Index (RSI) 43.49
Average Volume (20 Days) 32,701

Short Selling Information

The latest short interest is 37,467, so 0.81% of the outstanding shares have been sold short.

Short Interest 37,467
Short Previous Month 29,281
Short % of Shares Out 0.81%
Short % of Float 1.34%
Short Ratio (days to cover) 1.91

Income Statement

Revenue n/a
Gross Profit n/a
Operating Income -40.32M
Pretax Income -38.72M
Net Income -38.96M
EBITDA -40.06M
EBIT -40.32M
Earnings Per Share (EPS) -$11.81
Full Income Statement

Balance Sheet

The company has $54.20 million in cash and $36.80 million in debt, giving a net cash position of $17.40 million or $3.78 per share.

Cash & Cash Equivalents 54.20M
Total Debt 36.80M
Net Cash 17.40M
Net Cash Per Share $3.78
Equity (Book Value) 13.72M
Book Value Per Share 2.98
Working Capital n/a
Full Balance Sheet

Cash Flow

Operating Cash Flow n/a
Capital Expenditures n/a
Free Cash Flow n/a
FCF Per Share n/a
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

KALA BIO does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -53.04%
Shareholder Yield -53.04%
Earnings Yield -131.51%
FCF Yield n/a

Analyst Forecast

The average price target for KALA BIO is $15.00, which is 141.94% higher than the current price. The consensus rating is "Strong Buy".

Price Target $15.00
Price Target Difference 141.94%
Analyst Consensus Strong Buy
Analyst Count 2
Revenue Growth Forecast (5Y) n/a
EPS Growth Forecast (5Y) n/a
Stock Forecasts

Stock Splits

The last stock split was on October 21, 2022. It was a reverse split with a ratio of 0.02:1.

Last Split Date Oct 21, 2022
Split Type Reverse
Split Ratio 0.02:1

Scores

Altman Z-Score n/a
Piotroski F-Score n/a